Her kidney tumor, diagnosed in 1997, had spread to her abdomen, pancreas and both lungs.

FORBES: Swiss Army Medicine

It has high hopes for its new kidney cancer drug Afinitor, which helps patients whose disease is resistant to Pfizer's kidney tumor drug Sutent.

FORBES: Magazine Article

"I think it should change care" and that older patients should be told "that they don't necessarily need to have the kidney tumor removed, " said Dr. William Huang of New York University Langone Medical Center.

WSJ: Study questions kidney cancer treatment in elderly

The bulk of the tumor pressing on the liver or kidney can cause problems.

CNN: What is Hodgkin lymphoma's effect on the lymphatic system?

In the study, led by Marco Gerlinger and Charles Swanton at the London Research Institute, researchers obtained tumor tissue from four patients with kidney cancer.

WSJ: 'Personalized Medicine' Hits a Bump

At the same meeting Bayer and Onyx said their drug caused at least some tumor shrinkage in 42% of 89 kidney patients tested.

FORBES: Swiss Army Medicine

Kidney cancer had spread to his lungs and one tumor became so big it ate through his sternum and bulged right through the surface of his skin.

FORBES: Novartis Steals The Show

The patient was a woman with a large tumor in the adrenal gland atop her right kidney, and I had decided to remove it using a laparoscope.

NEWYORKER: Personal Best

In June oncologist Robert Motzer of New York's Memorial Sloan-Kettering Cancer Center reported that SU11248 dramatically shrank tumors in 33% of 63 kidney cancer patients tested (including Judy Norris) and halted tumor growth in another 37%.

FORBES: Health

On the FDA's Fast Track and in phase III testing is the company's BAY 43-9006, a small molecule RAF kinase and VEGF inhibitor that inhibits tumor growth for patients with metastatic renal cell carcinoma (advanced kidney cancer).

FORBES: Beware Of Biotechs At Cancer-Cure Prices